Aedin Culhane
Harvard University
H-index: 50
North America-United States
Top articles of Aedin Culhane
Immune-restoring CAR-T cells display antitumor activity and reverse immunosuppressive TME in a humanized ccRCC mouse model
Iscience
2024/2/16
demuxSNP: supervised demultiplexing scRNAseq using cell hashing and SNPs
bioRxiv
2024
Curated single cell multimodal landmark datasets for R/Bioconductor
PLOS Computational Biology
2023/8/25
Genome-scale functional genomics identify genes preferentially essential for multiple myeloma cells compared to other neoplasias
Nature Cancer
2023/5
fine-tuned CAIX targeted CAR-T cells exhibit superior efficacy and mitigate on-target off-tumor side effects
Cancer Research
2023/4/4
Correspondence analysis for dimension reduction, batch integration, and visualization of single-cell rna-seq data
Scientific Reports
2023/1/21
The Minimal Dataset for Cancer of the 1+ Million Genomes Initiative
bioRxiv
2023
P-182 Natural killer cells are active against myeloma cells with loss of tumor suppressor genes
Clinical Lymphoma Myeloma and Leukemia
2023/9/1
Multi-omic spatial profiling reveals the unique virus-driven immune landscape of COVID-19 placentitis
bioRxiv
2022/11/14
295 Affinity fine-tuning anti-CAIX CAR-T cells mitigate on-target off-tumor side effects
2022/11/1
Yufei Wang
H-Index: 2
Michael Lynch
H-Index: 66
David Braun
H-Index: 12
Matthew Chang
H-Index: 1
Brandon Piel
H-Index: 10
Zhu Zhu
H-Index: 3
Kevin Wei
H-Index: 17
Rebecca Jennings
H-Index: 8
Sabina Signoretti
H-Index: 76
Catherine Wu
H-Index: 1
Toni Choueiri
H-Index: 92
Aedin Culhane
H-Index: 32
David Barbie
H-Index: 39
Gordon Freeman
H-Index: 110
Anti-CAIX Immune Restoring (IR) CAR-T cells display superior antitumor activity and reverse immunosuppressive TME in a humanized ccRCC orthotopic mouse model
Cancer Research
2022/6/15
Anti-CAIX BBζ CAR4/8 T cells exhibit superior efficacy in a ccRCC mouse model
Molecular Therapy-Oncolytics
2022/3/17
Characteristics and outcomes of over 300,000 patients with COVID-19 and history of cancer in the United States and Spain
Cancer Epidemiology, Biomarkers & Prevention
2021/10
Genome-scale screens identify factors regulating tumor cell responses to natural killer cells
Nature Genetics
2021/8
development of dual-targeted fine-tuned immune restoring (DFIR) CAR T cell therapy for clear cell renal cell carcinoma (ccRCC)
Cancer Research
2021/7/1
Treatment-induced embryonic diapause-like adaptation through suppression of Myc activity as mediator of drug persistence in cancer
Cancer Research
2021/7/1
Ricardo De Matos Simoes
H-Index: 14
Aedin Culhane
H-Index: 32
Abstract GS1-07: Treatment persistence of residual breast tumors through an embryonic diapause-like cancer cell state with suppressed myc activity
Cancer Research
2021/2/15
An embryonic diapause-like adaptation with suppressed Myc activity enables tumor treatment persistence
Cancer cell
2021/2/8
Abstract PO041: Landscape of molecular events regulating tumor cell responses to natural killer cells
Cancer Immunology Research
2021/2/1
Characteristics and outcomes of 118,155 COVID-19 individuals with a history of cancer in the United States and Spain
medRxiv
2021/1/15
Waheed-Ul-Rahman Ahmed
H-Index: 5
Carlos Areia
H-Index: 7
William Carter
H-Index: 0
Thomas Falconer
H-Index: 8
George Hripcsak
H-Index: 47
Karthik Natarajan
H-Index: 13
Fredrik Nyberg
H-Index: 35
Anna Ostropolets
H-Index: 6
Nigam Shah
H-Index: 47
Yang Shen
H-Index: 68
Lin Zhang
H-Index: 9
Ying Zhang
H-Index: 4
Patrick Ryan
H-Index: 1
Co-Authors
